NIH-funded research R03 grant

Investigating how Candida albicans affects host cell behavior

Official title: Candida albicans Sap6 dysregulates host epithelial protease-antiprotease expression

Funded at State University of New York at Buffalo · NIH-10739848 · Data updated 2026-11-12

This study is looking at how a yeast called Candida albicans affects the cells in your mouth, especially how a specific protein it releases can change how those cells behave, with the goal of finding better ways to prevent and treat mouth infections, particularly for people with weakened immune systems.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2023
Award (this year)$321,542
NIH project number1R03DE032393-01A1
Project IDNIH-10739848 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are immunocompromised or critically ill and at risk for mucosal candidiasis.

Less likely to help

Patients with non-immunocompromised conditions or those not at risk for candidiasis may not benefit from this research.

What this research studies

This research focuses on understanding how the yeast Candida albicans interacts with oral epithelial cells, particularly how its secreted protease Sap6 alters the expression of host proteases and affects cell migration. By examining the mechanisms behind these changes, the study aims to identify potential targets for improving prevention and treatment of mucosal candidiasis, especially in vulnerable populations like the immunocompromised. The research involves laboratory experiments to analyze the effects of Sap6 on epithelial cell function and immune response.

Why it matters

Potential benefit: If successful, this research could lead to better prevention and treatment strategies for mucosal candidiasis, reducing morbidity and mortality in affected patients.

How similar studies have gone: Previous research has shown promising results in understanding the interactions between Candida albicans and host cells, indicating that this approach has potential for success.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Kumar, Rohitashw — State University of New York at Buffalo
  • Study coordinator: Kumar, Rohitashw

Related research

Other NIH-funded projects on the same topics.

  • Improving population health by studying reproductive health and development.

    This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-9795452

  • How noise and hearing loss affect the first step of hearing in the brain

    This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11620270

  • Programmable hydrogels to protect transplanted human OPCs in demyelinating disease

    Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11579956

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

  • New dual-acting treatments against tough Klebsiella pneumoniae infections

    A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11563773

  • Muscle health and aging in postmenopausal women

    This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11532334

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.